Evaluation of ammonia and lidocaine clearance, and galactose elimination capacity of xenoperfused pig livers using a pharmacokinetic analysis.
暂无分享,去创建一个
S. Satoh | Y. Yamaoka | I. Ikai | H. Okabe | R. Nishitai | H. Terajima | T. Uesugi | H. Iwata | T. Yoneyama | A. Kanazawa | T. Yoneyama | O. Takeyama | T. Yagi | H. Okabe | N. Katura | H. Iwata | Nagato Katura
[1] J. Villeneuve,et al. Determinants of Drug Disposition in Patients with Cirrhosis , 2007, Hepatology.
[2] H. Shinohara,et al. The protective effects of prostaglandin E1 on sinusoidal endothelial cells in xenogeneic pig liver perfusion. , 1997, Journal of Surgical Research.
[3] P. Olinga,et al. Value of the in vitro or in vivo monoethylglycinexylidide test for predicting liver graft function. , 1997, Transplantation.
[4] H. Shinohara,et al. Successful long-term xenoperfusion of the pig liver: continuous administration of prostaglandin E1 and insulin. , 1997, Transplantation.
[5] G. Budillon,et al. Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato. , 1996, Journal of hepatology.
[6] G. Marchesini,et al. The galactose elimination capacity test: a study of the technique based on the analysis of 868 measurements. , 1996, The American journal of gastroenterology.
[7] J. Hoofnagle,et al. Fulminant hepatic failure: Summary of a workshop , 1995, Hepatology.
[8] G. Alexander,et al. Serum alpha-glutathione S-transferase--a sensitive marker of hepatocellular damage associated with acute liver allograft rejection. , 1994, Transplantation.
[9] P. Parrilla,et al. Blood ammonia levels as early indicator of allograft viability in human orthotopic liver transplantation. , 1994, The American journal of gastroenterology.
[10] W. Meyers,et al. Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. , 1994, The New England journal of medicine.
[11] H. Jauregui,et al. Mammalian hepatocytes as a foundation for treatment in human liver failure , 1991, Journal of cellular biochemistry.
[12] M. Panteghini. Aspartate aminotransferase isoenzymes. , 1990, Clinical biochemistry.
[13] C. Gips,et al. AMMONIA KINETICS IN 8 PATIENTS WITH LIVER-DISEASE AND IN DOGS , 1987 .
[14] L. Ranek,et al. Assessment of Prognosis in Fulminant Hepatic Failure , 1986, Seminars in liver disease.
[15] N. Tygstrup,et al. Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig liver. , 1976, The American journal of physiology.
[16] G. Abouna,et al. Experience in the treatment of hepatic failure by intermittent liver hemoperfusions. , 1973, Surgery, gynecology & obstetrics.
[17] B. Eiseman,et al. Heterologous liver perfusion in treatment of hepatic failure. , 1965, Annals of surgery.
[18] S. Nyberg,et al. Pharmacokinetic analysis verifies P450 function during in vitro and in vivo application of a bioartificial liver. , 1993, ASAIO journal (1992).
[19] M. Rowland,et al. Clinical pharmacokinetics : concepts and applications , 1989 .
[20] C. Wittekind,et al. Monoethylglycinexylidide Formation Kinetics: A Novel Approach to Assessment of Liver Function , 1987, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
[21] S. Keiding,et al. Hepatic galactose elimination kinetics in the intact pig. , 1982, Scandinavian journal of clinical and laboratory investigation.
[22] R. Lutz,et al. Physiological pharmacokinetics: an in vivo approach to membrane transport. , 1980, Pharmacology & therapeutics.